Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 60,700
+5,100 (9.17%)
Jun 29, 2026, 3:30 PM KST
Mezzion Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -36,928 | -34,929 | -19,477 | -12,728 | -36,298 | -13,603 |
Depreciation & Amortization | 919.97 | 988.12 | 957.8 | 1,546 | 1,658 | 1,586 |
Loss (Gain) From Sale of Assets | -44.05 | -44.05 | 471.69 | -7.36 | -8.99 | 1.08 |
Asset Writedown & Restructuring Costs | - | - | - | - | 14,694 | - |
Stock-Based Compensation | 2,921 | 2,140 | 1,193 | 421.61 | 1,293 | 2,535 |
Provision & Write-off of Bad Debts | 5.93 | -4.93 | 162.76 | 87.18 | -20.93 | -124.47 |
Other Operating Activities | 20,314 | 18,521 | 5,282 | -1,128 | 677.64 | -4,327 |
Change in Accounts Receivable | 168.27 | -239.21 | 1,229 | 245.93 | -150.7 | 308.73 |
Change in Inventory | -19.58 | -16.78 | 209.7 | 2,643 | -313.17 | -4,786 |
Change in Accounts Payable | 107.08 | 177.64 | -2,456 | -3,152 | 1,474 | 1,780 |
Change in Other Net Operating Assets | -6,397 | -3,181 | -6,063 | 1,048 | 4,921 | 1,558 |
Operating Cash Flow | -18,952 | -16,588 | -18,489 | -11,023 | -12,075 | -15,071 |
Capital Expenditures | -60.97 | -137.39 | -590.49 | -529.29 | -767.56 | -357.81 |
Sale of Property, Plant & Equipment | 270.3 | 270.3 | - | 77.72 | 9.2 | - |
Cash Acquisitions | - | - | - | 1,192 | - | - |
Sale (Purchase) of Intangibles | -11,872 | -13,135 | -12,888 | -11,329 | -993.47 | -5,825 |
Investment in Securities | 5,000 | 15,000 | 3,000 | -14,967 | 19,157 | -10,151 |
Other Investing Activities | -1.43 | -1.43 | -0 | 0 | 5.11 | -0 |
Investing Cash Flow | -6,764 | 1,886 | -9,576 | -25,555 | 17,410 | -16,334 |
Short-Term Debt Issued | - | - | 880.09 | 3,226 | 4,832 | 3,744 |
Long-Term Debt Issued | - | 23,000 | - | - | - | - |
Total Debt Issued | 23,000 | 23,000 | 880.09 | 3,226 | 4,832 | 3,744 |
Short-Term Debt Repaid | - | - | -1,380 | -3,776 | -4,603 | -3,786 |
Long-Term Debt Repaid | - | -625.93 | -556.43 | -888.69 | -1,157 | -1,071 |
Total Debt Repaid | -594.9 | -625.93 | -1,936 | -4,665 | -5,760 | -4,857 |
Net Debt Issued (Repaid) | 22,405 | 22,374 | -1,056 | -1,439 | -927.79 | -1,114 |
Issuance of Common Stock | 4,577 | 4,357 | 1,726 | 48,653 | 312 | 225.77 |
Other Financing Activities | - | - | 0 | -0 | - | 20,000 |
Financing Cash Flow | 26,982 | 26,731 | 670.32 | 47,214 | -615.79 | 19,112 |
Foreign Exchange Rate Adjustments | 71.58 | -71.98 | 766.18 | 211.86 | 470.01 | 648.86 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | 1,338 | 11,957 | -26,629 | 10,847 | 5,189 | -11,644 |
Free Cash Flow | -19,013 | -16,725 | -19,080 | -11,553 | -12,842 | -15,429 |
Free Cash Flow Margin | -238.51% | -211.46% | -221.56% | -36.42% | -41.80% | -57.89% |
Free Cash Flow Per Share | -629.64 | -555.29 | -639.69 | -409.10 | -480.39 | -578.14 |
Cash Interest Paid | 334.89 | 317.82 | 293.66 | 220.24 | 26.77 | 7.99 |
Cash Income Tax Paid | - | 350.86 | 707.61 | 209.5 | 397.25 | 1,531 |
Levered Free Cash Flow | 14,554 | 12,379 | -21,362 | -18,701 | -3,264 | -17,413 |
Unlevered Free Cash Flow | 15,951 | 13,361 | -21,174 | -18,504 | -2,999 | -17,211 |
Change in Working Capital | -6,141 | -3,259 | -7,080 | 785.58 | 5,930 | -1,139 |